Mitsubishi UFJ Asset Management Co. Ltd. Reduces Position in Bruker Corporation $BRKR

Mitsubishi UFJ Asset Management Co. Ltd. trimmed its holdings in Bruker Corporation (NASDAQ:BRKR) by 23.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,863 shares of the medical research company’s stock after selling 8,345 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Bruker were worth $1,148,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Nisa Investment Advisors LLC grew its stake in Bruker by 377.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 616 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 487 shares in the last quarter. Allworth Financial LP lifted its stake in Bruker by 92.4% in the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company’s stock worth $30,000 after purchasing an additional 364 shares in the last quarter. Huntington National Bank boosted its holdings in shares of Bruker by 750.0% during the 2nd quarter. Huntington National Bank now owns 731 shares of the medical research company’s stock worth $30,000 after purchasing an additional 645 shares during the last quarter. Spire Wealth Management purchased a new stake in shares of Bruker in the second quarter valued at approximately $32,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Bruker by 1,354.5% in the first quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 745 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Cynthia M. Friend sold 3,535 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $32.25, for a total transaction of $114,003.75. Following the sale, the director owned 18,016 shares of the company’s stock, valued at approximately $581,016. This represents a 16.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John A. Ornell sold 6,233 shares of the firm’s stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $39.00, for a total transaction of $243,087.00. Following the completion of the transaction, the director directly owned 35,212 shares of the company’s stock, valued at approximately $1,373,268. The trade was a 15.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 27.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

BRKR has been the topic of a number of recent research reports. Cowen reissued a “hold” rating on shares of Bruker in a research note on Tuesday, November 4th. Stifel Nicolaus set a $40.00 target price on Bruker and gave the stock a “hold” rating in a research note on Tuesday, August 5th. TD Cowen boosted their price target on shares of Bruker from $40.00 to $42.00 and gave the company a “hold” rating in a research report on Tuesday, November 4th. Wells Fargo & Company dropped their price objective on shares of Bruker from $50.00 to $48.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Finally, Citigroup cut their price objective on shares of Bruker from $40.00 to $38.00 and set a “neutral” rating for the company in a research report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $48.30.

Bruker Stock Performance

Shares of Bruker stock opened at $41.62 on Friday. The firm has a market cap of $6.32 billion, a PE ratio of 80.04, a price-to-earnings-growth ratio of 5.31 and a beta of 1.26. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 52 week low of $28.53 and a 52 week high of $64.64. The business’s fifty day simple moving average is $36.04 and its 200-day simple moving average is $37.19.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Monday, November 3rd. The medical research company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.12. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm had revenue of $860.50 million for the quarter, compared to analyst estimates of $847.40 million. During the same period in the previous year, the firm earned $0.60 EPS. Bruker’s revenue was down .5% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. Equities analysts forecast that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Monday, December 8th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $0.20 annualized dividend and a yield of 0.5%. Bruker’s dividend payout ratio is presently -125.00%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.